Multiple Sclerosis Trial, Recruiting (NCT05072691)

Multiple Sclerosis Trial, Recruiting NCT05072691 Sponsor: Francis Corazza Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT05072691 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older at the time of enrolling in the trial
People who have been diagnosed with multiple sclerosis (a condition affecting the brain and nervous system) based on specific 2017 medical guidelines, or who have been diagnosed with optic neuritis (inflammation of the eye's optic nerve), whether or not a full multiple sclerosis diagnosis has been made
People who are already scheduled to have both a lumbar puncture (a procedure where a small amount of fluid is taken from the spine) and a brain MRI (a brain scan) as part of their routine medical investigation

Who may not be able to join:

There are no listed exclusion criteria for this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Serena Borrelli, CHU Brugmann

Phone: 3224750308

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05072691

Sponsor: Francis Corazza

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 3224750308

More information: https://clinicaltrials.gov/study/NCT05072691

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older at the time of enrolling in the trial
People who have been diagnosed with multiple sclerosis (a condition affecting the brain and nervous system) based on specific 2017 medical guidelines, or who have been diagnosed with optic neuritis (inflammation of the eye's optic nerve), whether or not a full multiple sclerosis diagnosis has been made
People who are already scheduled to have both a lumbar puncture (a procedure where a small amount of fluid is taken from the spine) and a brain MRI (a brain scan) as part of their routine medical investigation

Who may not be able to join:

There are no listed exclusion criteria for this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Francis Corazza

Registry

ClinicalTrials.gov

Start date

14 July 2020

Est. completion

1 January 2030

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Expanded Disability Status Scale (EDSS); Fatigue Severity Scale (FSS); Hospital Anxiety and Depression Scale (HADS); Symbol-Digit Modalities Test (SDMT); Nine Hole Peg Test (NHPT); Timed 25-Foot Walk (T25FW); Six Spot Step Test (SSST); Ambulation Score (AS); Annualized relapse rate (ARR); MRI data: T2 lesions; MRI data : gadolinium enhancing lesions; P100 latency (VEP); Visual acuity; Visual field; Color discrimination; GCL thickness (OCT); RNFL thickness (OCT); immunoglobulin (Ig) free light chains (FLC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov